recombinant DNA

(redirected from Recombinant technology)
Also found in: Dictionary, Thesaurus, Encyclopedia.

re·com·bi·nant DNA

altered DNA resulting from the insertion into the chain, by chemical, enzymatic, or biologic means, of a sequence (a whole or partial chain of DNA) not originally (biologically) present in that chain.

recombinant DNA

n. Abbr. rDNA
Genetically engineered DNA prepared by transplanting or splicing genes from one species into the cells of a host organism of a different species. Such DNA becomes part of the host's genetic makeup and is replicated.

recombinant DNA

DNA produced by the artificial linkage, in the laboratory or factory, of DNA from different sources. See also GENETIC ENGINEERING.

recombinant DNA

  1. DNA produced by joining together DNA sequences from different sources in vitro; often this involves VECTOR (2) DNA and foreign DNA to form a recombinant vector for use in GENETIC ENGINEERING.
  2. DNA produced by natural RECOMBINATION in vivo.
References in periodicals archive ?
"The approval of ATryn marks a significant milestone in the development of this innovative recombinant technology and delivers a new therapeutic option to benefit hereditary antithrombin deficient patients who are undergoing surgery or childbirth procedures," said Geoffrey F.
3rd Generation VIII produced by recombinant technology for the treatment of congenital bleeding disorders.
These new genes could potentially be utilized in our dual recombinant technology which will incorporate different angiogenic genes into unique combinations that may be used to optimize the treatment of particular cardiovascular diseases and patient populations."
Third-generation full-sized VIII molecule is produced by recombinant technology first.
Manon Cox, Protein Sciences' vice president, corporate development, commented, "We now have a broad relationship with Pasteur Merieux Connaught with four agreements that encompass three different approaches to bringing recombinant technology to influenza vaccines and an umbrella agreement that simplifies the process of initiating projects to develop new subunit vaccines for other diseases." She added, "This expanded relationship further demonstrates that baculovirus expression vector system is the system of choice for certain protein-based vaccines."
Octapharma AG endows 80 million to purchase a sole global license to some IP of Glycotope s recombinant technology and to be a small stakeholder of Glycotope GmbH Berlin.
Contract notice: Produced by recombinant technology for the treatment of a sale and purchase agreement with congenital haemophilia 1st generation viii.
Contract notice: Produced by recombinant technology, for the sale and purchase agreement for the treatment of congenital haemophilia 1st generation viii.
Part 1 A third-generation VIII produced by recombinant technology. factor concentrate (ATC code B02BD02) 1,440,000 IU;
Eposis (EPO), a haematopoietic agent produced by genetic recombinant technology, is effective in treating the anemia of patients with chronic renal failure and has been exported to Turkey, Vietnam, Thailand, Indonesia, Sri Lanka, Pakistan, Syria, etc.
VIII produced by recombinant technology. factor concentrate, 2 generation (ATC code: B02BD02) 8 000 000 IU; purchase contract of carriage.
This new research facility will help the company in carrying out innovative research in human recombinant technology. The new unit will have a clinical production line for development of new products researched at the centre.

Full browser ?